DRUGS ABUSE DETECTION TEST

Brand	Owner (click to sort)	Address	Description
ABUSIGN	PRINCETON BIOMEDITECH CORPORATION	4242 U.S. Highway 1 MONMOUTH JUNCTION NJ 08852	drugs of abuse detection test;ABU-SIGN;
ACCUSIGN	PRINCETON BIOMEDITECH CORPORATION	4242 U.S. Highway 1 MONMOUTH JUNCTION NJ 08852	drugs of abuse detection test;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention describes compounds, compositions and methods of using the same comprising lysine covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.